Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Odyssey Health (ODYY) Shares Outstanding (Weighted Average) (2016 - 2026)

Odyssey Health has reported Shares Outstanding (Weighted Average) over the past 8 years, most recently at $93.7 million for Q3 2021.

  • For Q3 2021, Shares Outstanding (Weighted Average) rose 7.59% year-over-year to $93.7 million; the TTM value through Jul 2021 reached $93.7 million, up 7.59%, while the annual FY2021 figure was $93.7 million, 7.59% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2021 was $93.7 million at Odyssey Health, roughly flat from $93.4 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $119.8 million in Q2 2018 and troughed at $14.8 million in Q4 2017.
  • A 5-year average of $91.9 million and a median of $93.4 million in 2021 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 87.07% in 2017 and later surged 313.85% in 2018.
  • Year by year, Shares Outstanding (Weighted Average) stood at $14.8 million in 2017, then surged by 313.85% to $61.4 million in 2018, then soared by 41.65% to $87.0 million in 2019, then grew by 3.78% to $90.3 million in 2020, then grew by 3.82% to $93.7 million in 2021.
  • Business Quant data shows Shares Outstanding (Weighted Average) for ODYY at $93.7 million in Q3 2021, $93.4 million in Q2 2021, and $93.7 million in Q1 2021.